Cargando…

The whole-PTH/intact-PTH ratio is a useful predictor of severity of secondary hyperparathyroidism

Background. The newer parathyroid hormone (PTH) assay, whole-PTH, uses an antibody that binds the region harbouring the first amino acid, making it specific for the complete molecule, 1–84-PTH. Especially among dialysis patients, it has been reported that the level of whole-PTH can be calculated as...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Motoko, Komaba, Hirotaka, Itoh, Kazuko, Matsushita, Kazunori, Matshushita, Kazutaka, Hamada, Yasuhiro, Fujii, Hideki, Fukagawa, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421130/
https://www.ncbi.nlm.nih.gov/pubmed/25983976
http://dx.doi.org/10.1093/ndtplus/sfn089
_version_ 1782369798634602496
author Tanaka, Motoko
Komaba, Hirotaka
Itoh, Kazuko
Matsushita, Kazunori
Matshushita, Kazutaka
Hamada, Yasuhiro
Fujii, Hideki
Fukagawa, Masafumi
author_facet Tanaka, Motoko
Komaba, Hirotaka
Itoh, Kazuko
Matsushita, Kazunori
Matshushita, Kazutaka
Hamada, Yasuhiro
Fujii, Hideki
Fukagawa, Masafumi
author_sort Tanaka, Motoko
collection PubMed
description Background. The newer parathyroid hormone (PTH) assay, whole-PTH, uses an antibody that binds the region harbouring the first amino acid, making it specific for the complete molecule, 1–84-PTH. Especially among dialysis patients, it has been reported that the level of whole-PTH can be calculated as ∼60% of their intact-PTH value. In addition, since 1–84-PTH is part of intact-PTH, the whole-PTH/intact-PTH ratio should not theoretically exceed 1. However, an abnormally high 1–84-PTH/intact-PTH ratio is reported in a few patients with parathyroid carcinoma, primary hyperparathyroidism and secondary hyperparathyroidism. In this study, we examined the correlation between the 1–84-PTH/intact-PTH ratio and the severity of hyperparathyroidism in patients on haemodialysis (HD). Patients and methods. The study population comprised 196 HD patients (males 113, females 83, age 67.4 ± 13.6 years, HD period 8.1 ± 7.3 years; mean ± SD). The whole-PTH/intact-PTH ratio was compared in patients with high PTH levels (intact-PTH ≥300 pg/ ml; high PTH group, n = 32), moderate PTH levels (intact-PTH >150–<300 pg/ml; moderate PTH group, n = 50) and low PTH levels (intact-PTH <150 pg/ml; low PTH group, n = 114). The ratio was also compared in 25 patients with at least one enlarged gland >0.5 cm(3) suggesting nodular hyperplasia, as determined by power Doppler ultrasonography (hyperplasia group) with seven patients without enlarged gland (non-hyperplasia group) and six patients who had undergone total parathyroidectomy (post-PTx group). Results. The whole-PTH/intact-PTH ratio of the high PTH group (0.68 ± 0.1) was significantly higher than those of the moderate (0.61 ± 0.1, P < 0.001) and low (0.52 ± 0.1, P < 0.001) groups. Moreover, the ratio was significantly higher in the hyperplasia group (0.70 ± 0.1) than those in the non-hyperplasia group (0.59 ± 0.1, P < 0.05) and post-PTx group (0.456 ± 0.12, P < 0.001). Conclusions. The whole-PTH/intact-PTH ratio correlated with the severity of hyperparathyroidism. Our results suggest that the ratio might be a useful predictor of severity of secondary hyperparathyroidism in HD patients.
format Online
Article
Text
id pubmed-4421130
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-44211302015-05-15 The whole-PTH/intact-PTH ratio is a useful predictor of severity of secondary hyperparathyroidism Tanaka, Motoko Komaba, Hirotaka Itoh, Kazuko Matsushita, Kazunori Matshushita, Kazutaka Hamada, Yasuhiro Fujii, Hideki Fukagawa, Masafumi NDT Plus Original Article Background. The newer parathyroid hormone (PTH) assay, whole-PTH, uses an antibody that binds the region harbouring the first amino acid, making it specific for the complete molecule, 1–84-PTH. Especially among dialysis patients, it has been reported that the level of whole-PTH can be calculated as ∼60% of their intact-PTH value. In addition, since 1–84-PTH is part of intact-PTH, the whole-PTH/intact-PTH ratio should not theoretically exceed 1. However, an abnormally high 1–84-PTH/intact-PTH ratio is reported in a few patients with parathyroid carcinoma, primary hyperparathyroidism and secondary hyperparathyroidism. In this study, we examined the correlation between the 1–84-PTH/intact-PTH ratio and the severity of hyperparathyroidism in patients on haemodialysis (HD). Patients and methods. The study population comprised 196 HD patients (males 113, females 83, age 67.4 ± 13.6 years, HD period 8.1 ± 7.3 years; mean ± SD). The whole-PTH/intact-PTH ratio was compared in patients with high PTH levels (intact-PTH ≥300 pg/ ml; high PTH group, n = 32), moderate PTH levels (intact-PTH >150–<300 pg/ml; moderate PTH group, n = 50) and low PTH levels (intact-PTH <150 pg/ml; low PTH group, n = 114). The ratio was also compared in 25 patients with at least one enlarged gland >0.5 cm(3) suggesting nodular hyperplasia, as determined by power Doppler ultrasonography (hyperplasia group) with seven patients without enlarged gland (non-hyperplasia group) and six patients who had undergone total parathyroidectomy (post-PTx group). Results. The whole-PTH/intact-PTH ratio of the high PTH group (0.68 ± 0.1) was significantly higher than those of the moderate (0.61 ± 0.1, P < 0.001) and low (0.52 ± 0.1, P < 0.001) groups. Moreover, the ratio was significantly higher in the hyperplasia group (0.70 ± 0.1) than those in the non-hyperplasia group (0.59 ± 0.1, P < 0.05) and post-PTx group (0.456 ± 0.12, P < 0.001). Conclusions. The whole-PTH/intact-PTH ratio correlated with the severity of hyperparathyroidism. Our results suggest that the ratio might be a useful predictor of severity of secondary hyperparathyroidism in HD patients. Oxford University Press 2008-08 /pmc/articles/PMC4421130/ /pubmed/25983976 http://dx.doi.org/10.1093/ndtplus/sfn089 Text en © The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Article
Tanaka, Motoko
Komaba, Hirotaka
Itoh, Kazuko
Matsushita, Kazunori
Matshushita, Kazutaka
Hamada, Yasuhiro
Fujii, Hideki
Fukagawa, Masafumi
The whole-PTH/intact-PTH ratio is a useful predictor of severity of secondary hyperparathyroidism
title The whole-PTH/intact-PTH ratio is a useful predictor of severity of secondary hyperparathyroidism
title_full The whole-PTH/intact-PTH ratio is a useful predictor of severity of secondary hyperparathyroidism
title_fullStr The whole-PTH/intact-PTH ratio is a useful predictor of severity of secondary hyperparathyroidism
title_full_unstemmed The whole-PTH/intact-PTH ratio is a useful predictor of severity of secondary hyperparathyroidism
title_short The whole-PTH/intact-PTH ratio is a useful predictor of severity of secondary hyperparathyroidism
title_sort whole-pth/intact-pth ratio is a useful predictor of severity of secondary hyperparathyroidism
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421130/
https://www.ncbi.nlm.nih.gov/pubmed/25983976
http://dx.doi.org/10.1093/ndtplus/sfn089
work_keys_str_mv AT tanakamotoko thewholepthintactpthratioisausefulpredictorofseverityofsecondaryhyperparathyroidism
AT komabahirotaka thewholepthintactpthratioisausefulpredictorofseverityofsecondaryhyperparathyroidism
AT itohkazuko thewholepthintactpthratioisausefulpredictorofseverityofsecondaryhyperparathyroidism
AT matsushitakazunori thewholepthintactpthratioisausefulpredictorofseverityofsecondaryhyperparathyroidism
AT matshushitakazutaka thewholepthintactpthratioisausefulpredictorofseverityofsecondaryhyperparathyroidism
AT hamadayasuhiro thewholepthintactpthratioisausefulpredictorofseverityofsecondaryhyperparathyroidism
AT fujiihideki thewholepthintactpthratioisausefulpredictorofseverityofsecondaryhyperparathyroidism
AT fukagawamasafumi thewholepthintactpthratioisausefulpredictorofseverityofsecondaryhyperparathyroidism
AT tanakamotoko wholepthintactpthratioisausefulpredictorofseverityofsecondaryhyperparathyroidism
AT komabahirotaka wholepthintactpthratioisausefulpredictorofseverityofsecondaryhyperparathyroidism
AT itohkazuko wholepthintactpthratioisausefulpredictorofseverityofsecondaryhyperparathyroidism
AT matsushitakazunori wholepthintactpthratioisausefulpredictorofseverityofsecondaryhyperparathyroidism
AT matshushitakazutaka wholepthintactpthratioisausefulpredictorofseverityofsecondaryhyperparathyroidism
AT hamadayasuhiro wholepthintactpthratioisausefulpredictorofseverityofsecondaryhyperparathyroidism
AT fujiihideki wholepthintactpthratioisausefulpredictorofseverityofsecondaryhyperparathyroidism
AT fukagawamasafumi wholepthintactpthratioisausefulpredictorofseverityofsecondaryhyperparathyroidism